Seal, Stopping Eczema and Allergy Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kari Nadeau, MD, PhD
Harvard
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- • King'S College London and Guy'S and St. Thomas' Nhs Foundation Trust, Uk
London, London, United Kingdom
- Sean N. Parker Center for Allergy & Asthma Research at Stanford University
Palo Alto, California, United States
- Division of Pediatric Allergy and Clinical Immunology, National Jewish Health
Denver, Colorado, United States
- University of Chicago
Chicago, Illinois, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2021
- Primary completion
- 31 May 2028
- Completion
- 30 Jun 2028
- Last update posted
- 27 Feb 2026
- Registered enrollment
- 398
- Registry id
- NCT03742414
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.